The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Pancreatic Ductal Adenocarcinoma: Is There a Survival Difference for R1 Resections Versus Locally Advanced Unresectable Tumors? What Is a “True” R0 Resection?
Open accessAbstract
In Brief Objective: Patients who undergo an R0 resection of their pancreatic ductal adenocarcinoma (PDAC) have an improved survival compared with patients who undergo an R1 resection. It is unclear whether an R1 resection confers a survival benefit over locally advanced (LA) unresectable tumors. Our aim was to compare the survival of patients undergoing an R1 resection with those having LA tumors and to explore the prognostic significance of a 1-mm surgical margin. Methods: Clinicopathologic data from a pancreatic cancer database between January 1993 and July 2008 were reviewed. Locally advanced tumors had no evidence of metastatic disease at exploration. Results: A total of 1705 patients were evaluated for PDAC in the Department of Surgery. Of the 1084 (64%) patients who were surgically explored, 530 (49%) were considered unresectable (286 locally unresectable, 244 with distant metastasis). One hundred fifty-seven (28%) of the resected PDACs had an R1 resection. Patients undergoing an R1 resection had a slightly longer survival compared with those who had locally advanced unresectable cancers (14 vs 11 months; P < 0.001). Patients with R0 resections had a favorable survival compared with those with R1 resections (23 vs 14 months; P < 0.001), but survival after resections with 1-mm margin or less (R0-close) were similar to R1 resections: both groups had a significantly shorter median survival than patients with a margin of greater than 1 mm (R0-wide) (16 vs 14 vs 35 months, respectively; P < 0.001). Conclusions: Patients undergoing an R1 resection still have an improved survival compared with patients with locally advanced unresectable pancreatic adenocarcinoma. R0 resections have an improved survival compared with R1 resections, but this survival benefit is lost when the tumor is within 1 mm of the resection margin. This report describes our experience with patients with locally advanced unresectable pancreatic ductal adenocarcinoma who were surgically explored between January 1993 and July 2008 at our institution and focuses on their survival compared with patients who underwent R1 resections during the same time period. We also examine the impact of the 1-mm surgical margin on the survival of patients who underwent resection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators
Sohn, T. A., Yeo, C. J., Cameron, J. L., Koniaris, L., Kaushal, S., Abrams, R. A., Sauter, P. K., Coleman, J., Hruban, R. H., & Lillemoe, K. D. (2000) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(00)80105-5 · Cited by 1,485
Self-citationPedrazzoli, S., DiCarlo, V., Dionigi, R., Mosca, F., Pederzoli, P., Pasquali, C., Klöppel, G., Dhaene, K., & Michelassi, F. (1998) · Annals of Surgery · doi:10.1097/00000658-199810000-00007 · Cited by 692
Neoptolemos, J. P., Stocken, D. D., Dunn, J., Almond, J., Beger, H. G., Pederzoli, P., Bassi, C., Dervenis, C., Fernández‐Cruz, L., LACAINE, F., et al. (2001) · Annals of Surgery · doi:10.1097/00000658-200112000-00007 · Cited by 670
Most Pancreatic Cancer Resections are R1 Resections
Esposito, I., Kleeff, J., Bergmann, F., Reiser, C., Herpel, E., Friess, H., Schirmacher, P., & Büchler, M. W. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9839-8 · Cited by 645
Redefining the R1 resection in pancreatic cancer
Verbeke, C. S., Leitch, D., Menon, K. V., McMahon, M. J., Guillou, P. J., & Anthoney, A. (2006) · British Journal of Surgery · doi:10.1002/bjs.5397 · Cited by 593
Raut, C. P., Tseng, J. F., Sun, C. C., Wang, H., Wolff, R. A., Crane, C. H., Hwang, R., Vauthey, J.-N., Abdalla, E. K., Lee, J. E., et al. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000259391.84304.2b · Cited by 564
Lu, D. S., Reber, H. A., Krasny, R. M., Kadell, B. M., & Sayre, J. (1997) · American Journal of Roentgenology · doi:10.2214/ajr.168.6.9168704 · Cited by 546
Margin Clearance and Outcome in Resected Pancreatic Cancer
Chang, D. K., Johns, A. L., Merrett, N. D., Gill, A. J., Colvin, E. K., Scarlett, C. J., Nguyen, N. Q., Leong, R. W. L., Cosman, P. H., Kelly, M. I., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5104 · Cited by 309
Surgical treatment of pancreatic adenocarcinoma
Kuhlmann, K. F. D., de Castro, S. M. M., Wesseling, J. G., ten Kate, F. J. W., Offerhaus, G. J. A., Busch, O. R. C., van Gulik, T. M., Obertop, H., & Gouma, D. J. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.10.026 · Cited by 286
Campbell, F., Smith, R. A., Whelan, P., Sutton, R., Raraty, M., Neoptolemos, J. P., & Ghaneh, P. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03376.x · Cited by 258
Cited by
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Self-citationFerrone, C. R., Marchegiani, G., Hong, T. S., Ryan, D. P., Deshpande, V., McDonnell, E. I., Sabbatino, F., Santos, D. D., Allen, J. N., Blaszkowsky, L. S., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000867 · Cited by 842
Self-citationOlivares, O., Mayers, J. R., Gouirand, V., Torrence, M. E., Gicquel, T., Borge, L., Lac, S., Roques, J., Lavaut, M.-N., Berthezène, P., et al. (2017) · Nature Communications · doi:10.1038/ncomms16031 · Cited by 413
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
Gemenetzis, G., Groot, V. P., Blair, A. B., Laheru, D. A., Zheng, L., Narang, A. K., Fishman, E. K., Hruban, R. H., Yu, J., Burkhart, R. A., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000002753 · Cited by 401
Improvement of surgical results for pancreatic cancer
Hartwig, W., Werner, J., Jäger, D., Debus, J., & Büchler, M. W. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70172-4 · Cited by 368
Pancreatic Cancer Surgery: The New R-status Counts
Strobel, O., Hank, T., Hinz, U., Bergmann, F., Schneider, L., Springfeld, C., Jäger, D., Schirmacher, P., Hackert, T., & Büchler, M. W. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000001731 · Cited by 344
Michelakos, T., Pergolini, I., Castillo, C. F.-D., Honselmann, K. C., Cai, L., Deshpande, V., Wo, J. Y., Ryan, D. P., Allen, J. N., Blaszkowsky, L. S., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000002600 · Cited by 324
Self-citationTumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma
Kalbasi, A., Komar, C., Tooker, G. M., Liu, M., Lee, J. W., Gladney, W. L., Ben-Josef, E., & Beatty, G. L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0870 · Cited by 305
Hartwig, W., Vollmer, C. M., Fingerhut, A., Yeo, C. J., Neoptolemos, J. P., Adham, M., Andrén-Sandberg, Å., Asbun, H. J., Bassi, C., Bockhorn, M., et al. (2014) · Surgery · doi:10.1016/j.surg.2014.02.009 · Cited by 288
Self-citationJones, R. P., Psarelli, E.-E., Jackson, R., Ghaneh, P., Halloran, C. M., Palmer, D. H., Campbell, F., Valle, J. W., Faluyi, O., O’Reilly, D. A., et al. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2019.3337 · Cited by 274
Metadata
- Authors
- Konstantinidis, I. T., Warshaw, A. L., Allen, J. N., Blaszkowsky, L. S., Castillo, C. F.-D., Deshpande, V., Hong, T. S., Kwak, E. L., Lauwers, G. Y., Ryan, D. P., Wargo, J. A., Lillemoe, K. D., & Ferrone, C. R.
- Venue
- Annals of Surgery
- Published
- 2013-04
- Volume
- 257
- Issue
- 4
- Pages
- 731-736
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2327072410
- Cited by
- 424
- References
- 16
- FWCI
- 10.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.